Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/6/2019 |
| Start Date: | February 27, 2019 |
| End Date: | September 30, 2021 |
| Contact: | Ashley Fansler, RN |
| Email: | arcarrol@wakehealth.edu |
| Phone: | 336-713-3539 |
The purpose of this research study is to determine if closing a surgical wound differently is
better than the procedure that is currently used. The wound will be closed with what is
considered "tertiary intent." This means, rather than leaving the wound open, the wound will
be partially closed after surgery, and then completely closed 4-7 days after surgery. The
investigators also want to see how this new wound closure process affects your quality of
life.
better than the procedure that is currently used. The wound will be closed with what is
considered "tertiary intent." This means, rather than leaving the wound open, the wound will
be partially closed after surgery, and then completely closed 4-7 days after surgery. The
investigators also want to see how this new wound closure process affects your quality of
life.
2.1 Primary Objective
To compare the percent of wound closure within 30 days in patients that received a tertiary
wound closure to historical controls receiving a secondary would closure. The investigators
are primarily looking at time to wound closure. The investigators will be able to abstract
this information from the postoperative clinic visit notes from patients in the "historical
control" cohort. The investigators will identify 20 patients with characteristics described
in the inclusion criteria of this study who underwent laparotomy with secondary would closure
during the calendar year 2018.
2.2 Secondary Objectives
To compare the proportion of acute and chronic wound infection in wounds closed with a
tertiary closure technique to historical controls receiving a secondary wound closure.
To compare the length of stay of patients receiving a tertiary wound closure to historical
controls receiving a secondary wound closure.
To describe the number of patients receiving a tertiary wound closure that return within 30
days of surgery as compared to historical controls receiving a secondary wound closure.
To describe the quality of life in patients receiving a tertiary wound closure.
To compare the percent of wound closure within 30 days in patients that received a tertiary
wound closure to historical controls receiving a secondary would closure. The investigators
are primarily looking at time to wound closure. The investigators will be able to abstract
this information from the postoperative clinic visit notes from patients in the "historical
control" cohort. The investigators will identify 20 patients with characteristics described
in the inclusion criteria of this study who underwent laparotomy with secondary would closure
during the calendar year 2018.
2.2 Secondary Objectives
To compare the proportion of acute and chronic wound infection in wounds closed with a
tertiary closure technique to historical controls receiving a secondary wound closure.
To compare the length of stay of patients receiving a tertiary wound closure to historical
controls receiving a secondary wound closure.
To describe the number of patients receiving a tertiary wound closure that return within 30
days of surgery as compared to historical controls receiving a secondary wound closure.
To describe the quality of life in patients receiving a tertiary wound closure.
Inclusion Criteria:
- Patients with high risk class II, class III, class IV abdominal wounds
- Undergoing laparotomy for gynecologic related disorders
- Patients undergoing laparotomy for both benign and malignant diagnoses will be
included in this study
Exclusion Criteria:
- Pregnancy
- Allergy to triclosan
- Patients undergoing HIPEC
We found this trial at
1
site
Medical Center Boulevard
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2255
Principal Investigator: Michael Kelly, MD
Phone: 336-713-3539
Comprehensive Cancer Center of Wake Forest University Our newly expanded Comprehensive Cancer Center is the...
Click here to add this to my saved trials
